Novel Immunotherapy Combos Target TIM-3 and PD-1/PD-L1 Networks

Press/Media

Period	7 Jan 2022

Media coverage

Title	Novel Immunotherapy Combos Target TIM-3 and PD-1/PD-L1 Networks
Media name/outlet	OncLive
Country/Territory	United States
Date	7/01/22
URL	https://www.onclive.com/view/novel-immunotherapy-combos-target-tim-3-and-pd-1-pd-l1-networks
Persons	Fred Hirsch, Fred Hirsch